BMS-345541 free base

CAS No. 445430-58-0

BMS-345541 free base( BMS345541 (free base) )

Catalog No. M14526 CAS No. 445430-58-0

A potent and selective IKK-2 inhibitor with IC50 of 0.3 uM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 91 In Stock
2MG 43 In Stock
5MG 69 In Stock
10MG 107 In Stock
25MG 217 In Stock
50MG 346 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BMS-345541 free base
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent and selective IKK-2 inhibitor with IC50 of 0.3 uM.
  • Description
    A potent and selective IKK-2 inhibitor with IC50 of 0.3 uM; less potent for IKK-1 (IC40=4 uM) and no activity against IKK-ε; inhibits LPS-stimulated TNFα, IL-1β, IL-8, and IL-6 in THP-1 cells with IC50 of1-5 uM; has excellent pharmacokinetics in mice.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    BMS345541 (free base)
  • Pathway
    Immunology/Inflammation
  • Target
    IκB kinase (IKK)
  • Recptor
    IKK1|IKK2
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    445430-58-0
  • Formula Weight
    255.3183
  • Molecular Formula
    C14H17N5
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    Cc1ccc2c(c1)n3c(cnc3c(n2)NCCN)C
  • Chemical Name
    1,2-Ethanediamine, N1-(1,8-dimethylimidazo[1,2-a]quinoxalin-4-yl)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Burke JR, et al. J Biol Chem. 2003 Jan 17;278(3):1450-6. 2. McIntyre KW, et al. Arthritis Rheum. 2003 Sep;48(9):2652-9. 3. López-Guerra M, et al. Clin Cancer Res. 2009 Apr 15;15(8):2767-76.
molnova catalog
related products
  • Bay 65-1942 R form

    The R form of Bay 65-1942. which is a potent, selective, ATP-competitive inhibitor of IKKβ kinase with Ki of 2 nM.

  • Bay 65-1942 hydrochl...

    A potent, selective, ATP-competitive inhibitor of IKKβ kinase with Ki of 2 nM.

  • AZD3264

    A novel IkB-kinase IKK2 inhibitor for treatment of inflammatory conditions such as asthma, chronic pulmonary obstructive disorder (COPD) and rheumatoid arthritis.